|
Researchers Develop Blood-Staunching Bandages
Conventional gauze bandages do not work well enough because, although they absorb blood, they do not prevent its flow. Thomas Fischer and colleagues at the Francis Owen Blood Research Laboratory at the University of North Carolina at Chapel Hill think they may have the solution.
GammaCan Receives FDA Orphan Drug Designation for Lead Product VitiGam(TM) for Stage IIB to Stage IV Melanoma
GammaCan International, Inc. a developer of proprietary immunotherapies for the treatment of melanoma and other cancers, announced its lead anti-cancer immunotherapy, VitiGam(TM), has received Orphan Drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of Stage IIB to Stage IV metastatic melanoma.
Aethlon Medical Submits Cancer Research Grant
Aethlon Medical, Inc. disclosed that it has submitted a cancer research grant application entitled "Affinity Capture of Circulating Cancer Biomarkers" to the National Institute of Health (NIH).
Mozobil™ Increases Number of Stem Cells Available for Transplant
According to the results of a Phase III clinical trial, treatment with the experimental drug Mozobil™ (plerixafor) increases the number of stem cells that can be collected from patients with non-Hodgkin’s lymphoma who are preparing for an autologous hematopoietic stem-cell transplant
Baxter Provides Update on Service Documentation Class I Recall
Baxter Healthcare Corporation announced an update to the July 25, 2007 Class I recall press release regarding falsified repair, test and inspection data sheets, which included electrical safety data for COLLEAGUE and FLO-GARD infusion pumps.
Rare Blood Virus Found in Almost 4 in 1,000 in Nunavut
Almost four in every 1,000 people in Nunavut may have a rare, incurable yet preventable virus called HTLV-1, a research report prepared for the Nunavut government has found
New Weapon in the Fight Against Blooddoping
With the test methods that are known today, it is extremely difficult to detect doping with your own blood. But with a new blood doping test developed by Australian and Danish researchers, the era of blood doping might have limited days.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Implementation of a Proficiency Testing Programme for Bacterial Screening in Platelet Preparations in Canada
The aim of this study was to develop, validate and implement an in-house proficiency testing programme to evaluate CBS performance of bacterial screening in platelet preparations.
Peripheral Blood Progenitor Cell Mobilization with Intermediate-Dose Cyclophosphamide, Sequential Granulocyte-Macrophage–Colony-Stimulating Factor and Granulocyte–Colony-Stimulating Factor, and Scheduled Commencement of Leukapheresis in 225 Patients Undergoing Autologous Transplantation
Interpatient variability in the kinetics of peripheral blood progenitor cell (PBPC) mobilization is commonly seen with conventional chemotherapy-based mobilization regimens.
Rapid and Effective CD3 T-Cell Depletion with a Magnetic Cell Sorting Program to Produce Peripheral Blood Progenitor Cell Products for Haploidentical Transplantation in Children and Adults
Effective T-cell depletion is a prerequisite for haploidentical peripheral blood progenitor cell (PBPC) transplantation. This study was performed to investigate the performance of magnetic cell sorting–based direct large-scale T-cell depletion, which is an attractive alternative to standard PBPC enrichment procedures.
|
